Published in Nat Rev Microbiol on November 06, 2013
LANA binds to multiple active viral and cellular promoters and associates with the H3K4methyltransferase hSET1 complex. PLoS Pathog (2014) 0.94
Herpesvirus Genome Recognition Induced Acetylation of Nuclear IFI16 Is Essential for Its Cytoplasmic Translocation, Inflammasome and IFN-β Responses. PLoS Pathog (2015) 0.93
Epstein-Barr virus late gene transcription depends on the assembly of a virus-specific preinitiation complex. J Virol (2014) 0.92
KSHV LANA--the master regulator of KSHV latency. Viruses (2014) 0.91
BRCA1 Regulates IFI16 Mediated Nuclear Innate Sensing of Herpes Viral DNA and Subsequent Induction of the Innate Inflammasome and Interferon-β Responses. PLoS Pathog (2015) 0.89
Evolution of plastic transmission strategies in avian malaria. PLoS Pathog (2014) 0.88
Association of Kaposi's Sarcoma-Associated Herpesvirus ORF31 with ORF34 and ORF24 Is Critical for Late Gene Expression. J Virol (2015) 0.85
Characterization of histone post-translational modifications during virus infection using mass spectrometry-based proteomics. Methods (2015) 0.84
Viral reprogramming of the Daxx histone H3.3 chaperone during early Epstein-Barr virus infection. J Virol (2014) 0.83
Resistant pathogens, fungi, and viruses. Surg Clin North Am (2014) 0.82
The Epstein-Barr Virus (EBV) in T Cell and NK Cell Lymphomas: Time for a Reassessment. Curr Hematol Malig Rep (2015) 0.82
Co-infection of Epstein-Barr virus and human papillomavirus in human tumorigenesis. Chin J Cancer (2016) 0.81
HITS-CLIP analysis uncovers a link between the Kaposi's sarcoma-associated herpesvirus ORF57 protein and host pre-mRNA metabolism. PLoS Pathog (2015) 0.80
Oncogenic Herpesvirus Utilizes Stress-Induced Cell Cycle Checkpoints for Efficient Lytic Replication. PLoS Pathog (2016) 0.79
Identification of MEF2B, EBF1, and IL6R as Direct Gene Targets of Epstein-Barr Virus (EBV) Nuclear Antigen 1 Critical for EBV-Infected B-Lymphocyte Survival. J Virol (2015) 0.79
Herpesvirus Late Gene Expression: A Viral-Specific Pre-initiation Complex Is Key. Front Microbiol (2016) 0.79
Regulation of herpesvirus reactivation by host microRNAs. J Virol (2014) 0.78
New insights into the expression and functions of the Kaposi's sarcoma-associated herpesvirus long noncoding PAN RNA. Virus Res (2015) 0.78
BET-Inhibitors Disrupt Rad21-Dependent Conformational Control of KSHV Latency. PLoS Pathog (2017) 0.77
Nanoparticle exposure reactivates latent herpesvirus and restores a signature of acute infection. Part Fibre Toxicol (2017) 0.77
Chromatinization of the KSHV Genome During the KSHV Life Cycle. Cancers (Basel) (2015) 0.77
Kaposi's sarcoma-associated herpesvirus stably clusters its genomes across generations to maintain itself extrachromosomally. J Cell Biol (2017) 0.76
Reactivation and Lytic Replication of Kaposi's Sarcoma-Associated Herpesvirus: An Update. Front Microbiol (2017) 0.75
Bacterial Short Chain Fatty Acids Push All The Buttons Needed To Reactivate Latent Viruses. Stem Cell Epigenet (2015) 0.75
Maintenance of Epstein-Barr Virus Latent Status by a Novel Mechanism, Latent Membrane Protein 1-Induced Interleukin-32, via the Protein Kinase Cδ Pathway. J Virol (2015) 0.75
Epstein-Barr virus (EBV)-encoded small RNAs (EBERs) associated with poor prognosis of head and neck carcinomas. Oncotarget (2017) 0.75
The C-Terminus of Epstein-Barr Virus BRRF2 Is Required for its Proper Localization and Efficient Virus Production. Front Microbiol (2017) 0.75
An Essential Viral Transcription Activator Modulates Chromatin Dynamics. PLoS Pathog (2016) 0.75
Histone H2B-IFI16 Recognition of Nuclear Herpesviral Genome Induces Cytoplasmic Interferon-β Responses. PLoS Pathog (2016) 0.75
BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha. J Virol (2016) 0.75
Replication-dependent and independent mechanisms for the chromosome-coupled persistence of a selfish genome. Nucleic Acids Res (2016) 0.75
Epigenetic Landscape of Kaposi's Sarcoma-Associated Herpesvirus Genome in Classic Kaposi's Sarcoma Tissues. PLoS Pathog (2017) 0.75
Deregulation of KSHV latency conformation by ER-stress and caspase-dependent RAD21-cleavage. PLoS Pathog (2017) 0.75
Structure and functional basis for an EBNA1 hexameric ring in Epstein-Barr Virus episome maintenance. J Virol (2017) 0.75
A bivalent chromatin structure marks key developmental genes in embryonic stem cells. Cell (2006) 48.80
ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer (2003) 16.06
CTCF: master weaver of the genome. Cell (2009) 15.09
Epstein-Barr virus: 40 years on. Nat Rev Cancer (2004) 9.70
IFI16 is an innate immune sensor for intracellular DNA. Nat Immunol (2010) 8.97
Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell (2010) 8.79
The functions of E(Z)/EZH2-mediated methylation of lysine 27 in histone H3. Curr Opin Genet Dev (2004) 7.89
Cancer epigenetics: from mechanism to therapy. Cell (2012) 7.74
CTCF is a uniquely versatile transcription regulator linked to epigenetics and disease. Trends Genet (2001) 6.80
Differences in B cell growth phenotype reflect novel patterns of Epstein-Barr virus latent gene expression in Burkitt's lymphoma cells. EMBO J (1987) 6.26
Efficient persistence of extrachromosomal KSHV DNA mediated by latency-associated nuclear antigen. Science (1999) 5.55
Daxx is an H3.3-specific histone chaperone and cooperates with ATRX in replication-independent chromatin assembly at telomeres. Proc Natl Acad Sci U S A (2010) 4.73
Cohesins localize with CTCF at the KSHV latency control region and at cellular c-myc and H19/Igf2 insulators. EMBO J (2008) 4.28
IFI16 acts as a nuclear pathogen sensor to induce the inflammasome in response to Kaposi Sarcoma-associated herpesvirus infection. Cell Host Microbe (2011) 4.01
The death-associated protein DAXX is a novel histone chaperone involved in the replication-independent deposition of H3.3. Genes Dev (2010) 4.00
Antibodies to butyrate-inducible antigens of Kaposi's sarcoma-associated herpesvirus in patients with HIV-1 infection. N Engl J Med (1996) 3.61
Kaposi's sarcoma and its associated herpesvirus. Nat Rev Cancer (2010) 3.55
The Rad50 zinc-hook is a structure joining Mre11 complexes in DNA recombination and repair. Nature (2002) 3.48
The nucleosomal surface as a docking station for Kaposi's sarcoma herpesvirus LANA. Science (2006) 3.46
Endothelial infection with KSHV genes in vivo reveals that vGPCR initiates Kaposi's sarcomagenesis and can promote the tumorigenic potential of viral latent genes. Cancer Cell (2003) 3.42
PML and PML nuclear bodies: implications in antiviral defence. Biochimie (2007) 3.26
The expression pattern of Epstein-Barr virus latent genes in vivo is dependent upon the differentiation stage of the infected B cell. Immunity (2000) 2.96
Chromatin regulates origin activity in Drosophila follicle cells. Nature (2004) 2.78
Regulation of nucleosome dynamics by histone modifications. Nat Struct Mol Biol (2013) 2.71
The coupling of synthesis and partitioning of EBV's plasmid replicon is revealed in live cells. EMBO J (2007) 2.71
Charting latency transcripts in Kaposi's sarcoma-associated herpesvirus by whole-genome real-time quantitative PCR. J Virol (2002) 2.71
The structure of the termini of the DNA of Epstein-Barr virus. Cell (1979) 2.69
Why do viruses cause cancer? Highlights of the first century of human tumour virology. Nat Rev Cancer (2010) 2.68
Review: properties and assembly mechanisms of ND10, PML bodies, or PODs. J Struct Biol (2000) 2.50
Establishment of an oriP replicon is dependent upon an infrequent, epigenetic event. Mol Cell Biol (2001) 2.44
Transcription profile of Kaposi's sarcoma-associated herpesvirus in primary Kaposi's sarcoma lesions as determined by real-time PCR arrays. Cancer Res (2003) 2.37
An ATM/Chk2-mediated DNA damage-responsive signaling pathway suppresses Epstein-Barr virus transformation of primary human B cells. Cell Host Microbe (2010) 2.23
Nuclear IFI16 induction of IRF-3 signaling during herpesviral infection and degradation of IFI16 by the viral ICP0 protein. Proc Natl Acad Sci U S A (2012) 2.14
Cohesin: genomic insights into controlling gene transcription and development. Curr Opin Genet Dev (2011) 2.12
Kaposi's sarcoma-associated herpesvirus latency-associated nuclear antigen interacts with bromodomain protein Brd4 on host mitotic chromosomes. J Virol (2006) 2.11
EBP2, a human protein that interacts with sequences of the Epstein-Barr virus nuclear antigen 1 important for plasmid maintenance. J Virol (1999) 2.07
Does CTCF mediate between nuclear organization and gene expression? Bioessays (2010) 2.02
B cell activation and the establishment of Epstein-Barr virus latency. J Exp Med (1988) 2.00
Epigenetic regulation of Kaposi's sarcoma-associated herpesvirus latency by virus-encoded microRNAs that target Rta and the cellular Rbl2-DNMT pathway. J Virol (2010) 1.98
ORC, MCM, and histone hyperacetylation at the Kaposi's sarcoma-associated herpesvirus latent replication origin. J Virol (2004) 1.97
The epigenetic landscape of latent Kaposi sarcoma-associated herpesvirus genomes. PLoS Pathog (2010) 1.97
Epigenetic analysis of KSHV latent and lytic genomes. PLoS Pathog (2010) 1.94
Genomic study of replication initiation in human chromosomes reveals the influence of transcription regulation and chromatin structure on origin selection. Mol Biol Cell (2009) 1.94
DNA looping between the origin of replication of Epstein-Barr virus and its enhancer site: stabilization of an origin complex with Epstein-Barr nuclear antigen 1. Proc Natl Acad Sci U S A (1991) 1.86
Differential regulation of the overlapping Kaposi's sarcoma-associated herpesvirus vGCR (orf74) and LANA (orf73) promoters. J Virol (2001) 1.84
The EBV lytic switch protein, Z, preferentially binds to and activates the methylated viral genome. Nat Genet (2004) 1.82
Transcriptional activation by EBV nuclear antigen 1 is essential for the expression of EBV's transforming genes. Proc Natl Acad Sci U S A (2006) 1.81
The ephrin receptor tyrosine kinase A2 is a cellular receptor for Kaposi's sarcoma–associated herpesvirus. Nat Med (2012) 1.72
Genomes in conflict: maintaining genome integrity during virus infection. Annu Rev Microbiol (2010) 1.72
When Epstein-Barr virus persistently infects B-cell lines, it frequently integrates. J Virol (1991) 1.70
Chromatin remodeling of the Kaposi's sarcoma-associated herpesvirus ORF50 promoter correlates with reactivation from latency. J Virol (2003) 1.70
A unique herpesviral transcriptional program in KSHV-infected lymphatic endothelial cells leads to mTORC1 activation and rapamycin sensitivity. Cell Host Microbe (2013) 1.69
Visualization of DNA replication on individual Epstein-Barr virus episomes. Science (2001) 1.68
In vivo-restricted and reversible malignancy induced by human herpesvirus-8 KSHV: a cell and animal model of virally induced Kaposi's sarcoma. Cancer Cell (2007) 1.68
Disruption of Kaposi's sarcoma-associated herpesvirus latent nuclear antigen leads to abortive episome persistence. J Virol (2004) 1.64
Reactivation of Epstein-Barr virus from latency. Rev Med Virol (2005) 1.58
Acetylation of the latency-associated nuclear antigen regulates repression of Kaposi's sarcoma-associated herpesvirus lytic transcription. J Virol (2006) 1.57
Lytic cycle switches of oncogenic human gammaherpesviruses. Adv Cancer Res (2007) 1.57
Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett (2009) 1.54
Early events in Kaposi's sarcoma-associated herpesvirus infection of target cells. J Virol (2009) 1.54
CTCF: insights into insulator function during development. Development (2012) 1.53
Transcripts encoding K12, v-FLIP, v-cyclin, and the microRNA cluster of Kaposi's sarcoma-associated herpesvirus originate from a common promoter. J Virol (2005) 1.50
The histone variant H3.3 regulates gene expression during lytic infection with herpes simplex virus type 1. J Virol (2008) 1.48
Stochastic expression of the interferon-β gene. PLoS Biol (2012) 1.47
Herpes simplex virus 1 infection induces activation and subsequent inhibition of the IFI16 and NLRP3 inflammasomes. J Virol (2013) 1.46
Mouse cytomegalovirus immediate-early protein 1 binds with host cell repressors to relieve suppressive effects on viral transcription and replication during lytic infection. J Virol (2003) 1.43
The Kaposi's sarcoma-associated herpesvirus K12 transcript from a primary effusion lymphoma contains complex repeat elements, is spliced, and initiates from a novel promoter. J Virol (2002) 1.41
Cell cycle regulation of chromatin at an origin of DNA replication. EMBO J (2005) 1.40
Structure and function of latency-associated nuclear antigen. Curr Top Microbiol Immunol (2007) 1.39
An atlas of the Epstein-Barr virus transcriptome and epigenome reveals host-virus regulatory interactions. Cell Host Microbe (2012) 1.38
Transcription-associated histone modifications and cryptic transcription. Biochim Biophys Acta (2012) 1.38
Kaposi's sarcoma-associated herpesvirus interacts with EphrinA2 receptor to amplify signaling essential for productive infection. Proc Natl Acad Sci U S A (2012) 1.38
bZIP proteins of human gammaherpesviruses. J Gen Virol (2003) 1.37
RNA-dependent recruitment of the origin recognition complex. EMBO J (2008) 1.37
PU box-binding transcription factors and a POU domain protein cooperate in the Epstein-Barr virus (EBV) nuclear antigen 2-induced transactivation of the EBV latent membrane protein 1 promoter. J Gen Virol (1995) 1.36
Structure and role of the terminal repeats of Epstein-Barr virus in processing and packaging of virion DNA. J Virol (1995) 1.35
Chromatin profiling of Epstein-Barr virus latency control region. J Virol (2007) 1.34
The BAH domain facilitates the ability of human Orc1 protein to activate replication origins in vivo. EMBO J (2006) 1.34
Cohesin regulation: fashionable ways to wear a ring. Chromosoma (2007) 1.34
Plasticity of DNA replication initiation in Epstein-Barr virus episomes. PLoS Biol (2004) 1.34
Dynamic chromatin boundaries delineate a latency control region of Epstein-Barr virus. J Virol (2004) 1.33
Constitutive interferon-inducible protein 16-inflammasome activation during Epstein-Barr virus latency I, II, and III in B and epithelial cells. J Virol (2013) 1.33
ZEB1 regulates the latent-lytic switch in infection by Epstein-Barr virus. PLoS Pathog (2007) 1.33
The pathogenesis of Epstein-Barr virus persistent infection. Curr Opin Virol (2013) 1.33
BZLF1 activation of the methylated form of the BRLF1 immediate-early promoter is regulated by BZLF1 residue 186. J Virol (2005) 1.30
Innate immune sensing of DNA viruses. Virology (2011) 1.30
Role for G-quadruplex RNA binding by Epstein-Barr virus nuclear antigen 1 in DNA replication and metaphase chromosome attachment. J Virol (2009) 1.29
CpG-methylation regulates a class of Epstein-Barr virus promoters. PLoS Pathog (2010) 1.28
Mediation of Epstein-Barr virus EBNA-LP transcriptional coactivation by Sp100. EMBO J (2005) 1.28
Epigenetic repression of p16(INK4A) by latent Epstein-Barr virus requires the interaction of EBNA3A and EBNA3C with CtBP. PLoS Pathog (2010) 1.27
CTCF prevents the epigenetic drift of EBV latency promoter Qp. PLoS Pathog (2010) 1.27
Circularization of the herpes simplex virus type 1 genome upon lytic infection. J Virol (2005) 1.25
The chromatin response to DNA breaks: leaving a mark on genome integrity. Annu Rev Biochem (2013) 1.25
ZEB negatively regulates the lytic-switch BZLF1 gene promoter of Epstein-Barr virus. J Virol (2003) 1.25
Differential role of Sp100 isoforms in interferon-mediated repression of herpes simplex virus type 1 immediate-early protein expression. J Virol (2006) 1.24
Role of EBNA-1 in arresting replication forks at the Epstein-Barr virus oriP family of tandem repeats. Mol Cell Biol (1991) 1.23
Kaposi's sarcoma-associated herpesvirus latency in endothelial and B cells activates gamma interferon-inducible protein 16-mediated inflammasomes. J Virol (2013) 1.22